First Light Asset Management as of Dec. 31, 2013
Portfolio Holdings for First Light Asset Management
First Light Asset Management holds 66 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| AtriCure (ATRC) | 9.5 | $11M | 599k | 18.68 | |
| Spectranetics Corporation | 5.0 | $6.0M | 238k | 25.00 | |
| RTI Biologics | 4.2 | $5.0M | 1.4M | 3.54 | |
| Tearlab Corp | 4.0 | $4.8M | 509k | 9.34 | |
| Lannett Company | 3.9 | $4.7M | 141k | 33.10 | |
| Quidel Corporation | 3.7 | $4.4M | 141k | 30.89 | |
| Array BioPharma | 3.6 | $4.3M | 860k | 5.01 | |
| Akorn | 3.6 | $4.2M | 172k | 24.62 | |
| NeoGenomics (NEO) | 3.4 | $4.0M | 1.1M | 3.62 | |
| Sunopta (STKL) | 3.1 | $3.7M | 367k | 10.01 | |
| Streamline Health Solutions | 2.9 | $3.4M | 491k | 6.98 | |
| Volcano Corporation | 2.8 | $3.3M | 152k | 21.85 | |
| Omnicell (OMCL) | 2.7 | $3.2M | 124k | 25.53 | |
| Ligand Pharmaceuticals In (LGND) | 2.7 | $3.2M | 60k | 52.60 | |
| Accelrys | 2.5 | $3.0M | 313k | 9.54 | |
| Celldex Therapeutics | 2.4 | $2.8M | 116k | 24.21 | |
| Novadaq Technologies | 2.4 | $2.8M | 170k | 16.49 | |
| STAAR Surgical Company (STAA) | 2.2 | $2.7M | 164k | 16.19 | |
| D Fluidigm Corp Del (LAB) | 1.9 | $2.2M | 58k | 38.28 | |
| Cepheid | 1.8 | $2.1M | 45k | 46.66 | |
| Alkermes (ALKS) | 1.8 | $2.1M | 51k | 40.66 | |
| NPS Pharmaceuticals | 1.8 | $2.1M | 68k | 30.36 | |
| HealthStream (HSTM) | 1.7 | $2.0M | 60k | 32.63 | |
| Advisory Board Company | 1.5 | $1.8M | 29k | 63.68 | |
| Arthrocare Corp | 1.5 | $1.8M | 44k | 40.24 | |
| GenMark Diagnostics | 1.3 | $1.6M | 118k | 13.29 | |
| Align Tech | 1.3 | $1.5M | 27k | 57.14 | |
| LeMaitre Vascular (LMAT) | 1.3 | $1.5M | 189k | 8.01 | |
| Sagent Pharmaceuticals | 1.2 | $1.4M | 56k | 25.39 | |
| Endologix | 1.1 | $1.3M | 76k | 17.44 | |
| Masimo Corporation (MASI) | 1.1 | $1.3M | 45k | 29.23 | |
| BioMarin Pharmaceutical (BMRN) | 1.0 | $1.1M | 16k | 70.36 | |
| Aratana Therapeutics | 0.9 | $1.0M | 54k | 19.10 | |
| Covidien | 0.8 | $993k | 15k | 68.11 | |
| AngioDynamics (ANGO) | 0.8 | $976k | 57k | 17.16 | |
| Orexigen Therapeutics | 0.8 | $962k | 171k | 5.63 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 0.8 | $967k | 13k | 74.28 | |
| Vivus | 0.8 | $887k | 98k | 9.08 | |
| Synergetics USA | 0.7 | $851k | 235k | 3.62 | |
| Cytokinetics (CYTK) | 0.7 | $848k | 131k | 6.50 | |
| HeartWare International | 0.7 | $843k | 9.0k | 93.91 | |
| Thoratec Corporation | 0.7 | $787k | 22k | 36.59 | |
| Endo Pharmaceuticals | 0.5 | $616k | 9.1k | 67.51 | |
| Novartis (NVS) | 0.4 | $488k | 6.1k | 80.40 | |
| Forest Laboratories | 0.4 | $458k | 7.6k | 59.99 | |
| Bristol Myers Squibb (BMY) | 0.4 | $441k | 8.3k | 53.20 | |
| United Therapeutics Corporation (UTHR) | 0.4 | $432k | 3.8k | 113.09 | |
| Mylan | 0.4 | $424k | 9.8k | 43.38 | |
| WellPoint | 0.3 | $378k | 4.1k | 92.31 | |
| St. Jude Medical | 0.3 | $375k | 6.1k | 61.93 | |
| Humana (HUM) | 0.3 | $365k | 3.5k | 103.11 | |
| Celgene Corporation | 0.3 | $362k | 2.1k | 169.16 | |
| Johnson & Johnson (JNJ) | 0.3 | $350k | 3.8k | 91.62 | |
| Aetna | 0.3 | $358k | 5.2k | 68.65 | |
| Astrazeneca | 0.3 | $337k | 5.7k | 59.33 | |
| Merck & Co (MRK) | 0.3 | $331k | 6.6k | 50.08 | |
| Pfizer (PFE) | 0.3 | $322k | 11k | 30.61 | |
| Steris Corporation | 0.3 | $304k | 6.3k | 48.03 | |
| CareFusion Corporation | 0.3 | $308k | 7.7k | 39.84 | |
| Sanofi-Aventis SA (SNY) | 0.3 | $305k | 5.7k | 53.70 | |
| BECTON DICKINSON & CO Com Stk | 0.3 | $309k | 2.8k | 110.55 | |
| Agilent Technologies Inc C ommon (A) | 0.2 | $293k | 5.1k | 57.23 | |
| Eli Lilly & Co. (LLY) | 0.2 | $280k | 5.5k | 50.96 | |
| Amgen | 0.2 | $266k | 2.3k | 114.16 | |
| Community Health Systems (CYH) | 0.2 | $241k | 6.1k | 39.22 | |
| BIO-RAD LABORATORIES Inc Cl A Com Stk | 0.2 | $207k | 1.7k | 123.58 |
